This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Resumen de acción IPA
ImmunoPrecise Antibodies Ltd., together with its subsidiaries, operates as a biotherapeutic research and technology company in Canada and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Competidores de ImmunoPrecise Antibodies Ltd.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | CA$6.50 |
| 52 Week High | CA$8.81 |
| 52 Week Low | CA$4.52 |
| Beta | 0.30 |
| 1 Month Change | -3.70% |
| 3 Month Change | -16.77% |
| 1 Year Change | -23.26% |
| 3 Year Change | 103.13% |
| 5 Year Change | 160.00% |
| Change since IPO | 0.77% |
Noticias y actualizaciones recientes
Rentabilidad de los accionistas
| IPA | CA Life Sciences | Mercado CA | |
|---|---|---|---|
| 7D | -6.5% | 0.08% | -0.2% |
| 1Y | -23.3% | 1.1% | 7.0% |
Rentabilidad vs. Industria: IPA exceeded the Canadian Life Sciences industry which returned -28.3% over the past year.
Rentabilidad vs. Mercado: IPA underperformed the Canadian Market which returned -1.4% over the past year.
Volatilidad de los precios
| IPA volatility | |
|---|---|
| IPA Average Weekly Movement | 10.3% |
| Life Sciences Industry Average Movement | 6.9% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in CA Market | 18.2% |
| 10% least volatile stocks in CA Market | 3.1% |
Precio estable de las acciones: IPA's share price has been volatile over the past 3 months.
Volatilidad a lo largo del tiempo: IPA's weekly volatility (10%) has been stable over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1983 | 85 | Jennifer Bath | www.ipatherapeutics.com |
Resumen de fundamentos de ImmunoPrecise Antibodies Ltd.
| Estadísticas fundamentales de IPA | |
|---|---|
| Capitalización bursátil | CA$162.08m |
| Beneficios(TTM) | -CA$22.86m |
| Ingresos (TTM) | CA$19.47m |
8.3x
Ratio precio-ventas (PS)-7.1x
Ratio precio-beneficio (PE)¿Está IPA sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de IPA | |
|---|---|
| Ingresos | CA$19.47m |
| Coste de los ingresos | CA$8.70m |
| Beneficio bruto | CA$10.76m |
| Otros gastos | CA$33.62m |
| Beneficios | -CA$22.86m |
Últimos beneficios comunicados
Jul 31, 2022
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -0.92 |
| Margen bruto | 55.29% |
| Margen de beneficio neto | -117.44% |
| Ratio deuda/patrimonio | 0% |
¿Cómo se ha desempeñado IPA a largo plazo?
Ver rendimiento histórico y comparativa